97 related articles for article (PubMed ID: 8087706)
1. Intermittent intravenous treatment of lupus nephritis with cyclophosphamide: a four-year experience with twenty-four patients.
Chu SJ; Chang DM; Kuo SY; Hsu CM; Chen CM; Chang ML
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jun; 53(6):325-30. PubMed ID: 8087706
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
[TBL] [Abstract][Full Text] [Related]
3. Sequential evaluation of clinical and laboratory changes amongst children suffering from lupus nephritis during intermittent intravenous cyclophosphamide therapy.
Chiu SJ; Ou LS; Tsai TL; Hung IJ; Huang JL
Clin Rheumatol; 2006 Jul; 25(4):515-9. PubMed ID: 16283418
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
[TBL] [Abstract][Full Text] [Related]
5. Intravenous cyclophosphamide for lupus nephritis in Thai children.
Vachvanichsanong P; Dissaneewate P; Winn T
Scand J Rheumatol; 2004; 33(5):339-42. PubMed ID: 15513684
[TBL] [Abstract][Full Text] [Related]
6. Intravenous cyclophosphamide pulse therapy on children with severe active lupus nephritis.
Yan DC; Chou CC; Tsai MJ; Chiang BL; Tsau YK; Hsieh KH
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(3):203-9. PubMed ID: 7618472
[TBL] [Abstract][Full Text] [Related]
7. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
Valeri A; Radhakrishnan J; Estes D; D'Agati V; Kopelman R; Pernis A; Flis R; Pirani C; Appel GB
Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
[TBL] [Abstract][Full Text] [Related]
8. Clinical effects of intermittent, intravenous cyclophosphamide in severe systemic lupus erythematosus.
Martinelli R; Pereira LJ; Santos ES; Rocha H
Nephron; 1996; 74(2):313-7. PubMed ID: 8893147
[TBL] [Abstract][Full Text] [Related]
9. Intermittent intravenous cyclophosphamide therapy for lupus nephritis.
Lehman TJ; Sherry DD; Wagner-Weiner L; McCurdy DK; Emery HM; Magilavy DB; Kovalesky A
J Pediatr; 1989 Jun; 114(6):1055-60. PubMed ID: 2656961
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive therapy in lupus nephritis.
D'Cruz D; Cuadrado MJ; Mujic F; Tungekar MF; Taub N; Lloyd M; Khamashta MA; Hughes GR
Clin Exp Rheumatol; 1997; 15(3):275-82. PubMed ID: 9177922
[TBL] [Abstract][Full Text] [Related]
11. [Appraisal of renal failure reversing therapies in lupus nephritis].
Yang X; Liang L; Zhan Z; Ye Y; Liu Y; Yu X; Chen W; Yin P
Zhonghua Nei Ke Za Zhi; 2001 Feb; 40(2):113-6. PubMed ID: 11798566
[TBL] [Abstract][Full Text] [Related]
12. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
[TBL] [Abstract][Full Text] [Related]
13. Intermittent intravenous pulse cyclophosphamide treatment in systemic lupus erythematosus.
Malaviya AN; Singh RR; Sindhwani R; Singh YN; Ahujà RK; Bhuyan UN; Khare SD; Kumar A; Malaviya R; Negi PC
Indian J Med Res; 1992 Apr; 96():101-8. PubMed ID: 1428048
[TBL] [Abstract][Full Text] [Related]
14. Crossroads of the effects of cyclophosphamide pulse therapy for lupus nephritis--experience of 11 cases.
Funauchi M; Ikoma S; Sugiyama M; Yu H; Ohno M; Kinoshita K; Hamada K; Kanamaru A
J Clin Lab Immunol; 1998; 50(2):45-54. PubMed ID: 10470622
[TBL] [Abstract][Full Text] [Related]
15. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.
Yee CS; Gordon C; Dostal C; Petera P; Dadoniene J; Griffiths B; Rozman B; Isenberg DA; Sturfelt G; Nived O; Turney JH; Venalis A; Adu D; Smolen JS; Emery P
Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482
[TBL] [Abstract][Full Text] [Related]
16. Pulse cyclophospamide in severe lupus nephritis: Southern Indian experience.
Das U; Dakshina Murty KV; Prasad N; Prayag A
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):372-8. PubMed ID: 20228536
[TBL] [Abstract][Full Text] [Related]
17. Intravenous pulse cyclophosphamide in the treatment of type IV lupus nephritis.
Eiser AR; Grishman E; Dreznin S
Clin Nephrol; 1993 Sep; 40(3):155-9. PubMed ID: 8403570
[TBL] [Abstract][Full Text] [Related]
18. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
[TBL] [Abstract][Full Text] [Related]
19. [Intravenous cyclophosphamide in lupus nephritis: twenty years reducing dose].
Frutos MA; Martín Gómez A; de Ramón E; Camps MT; Valera A; García I; Fernández Nebro A
Nefrologia; 2007; 27(1):12-22. PubMed ID: 17402875
[TBL] [Abstract][Full Text] [Related]
20. Outcome of 85 lupus nephritis patients treated with intravenous cyclophosphamide: a single centre 10 year experience.
Chan AY; Hooi LS
Med J Malaysia; 2000 Mar; 55(1):14-20. PubMed ID: 11072485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
